News
The U.S. Government Accountability Office (GAO) says that steps are being taken to address healthcare fraud. For one thing, ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...
The drugs reportedly under consideration for coverage include Novo Nordisk's Wegovy and Ozempic, and Eli Lilly's Zepbound and ...
The Trump administration, CMS, and over 60 companies including Apple have announced a new nationwide digital health ecosystem ...
A new rule issued by the Centers for Medicare and Medicaid Services will strip DACA recipients of eligibility for coverage ...
A major cybersecurity incident has exposed sensitive personal and health records of tens of thousands of Americans.
Company doubles down on its commitment to transform personal health journey of every American at invitation-only Health Tech Ecosystem event at the White House ...
The Centers for Medicare & Medicaid Services awarded the Department of Public Health and Social Services $39 million for the ...
The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results